piperaquine has been researched along with Long QT Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aweeka, F; Clark, TD; Dorsey, G; Hughes, E; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Ochieng, T; Rosenthal, PJ; Savic, RM; Wallender, E | 1 |
| Baro, B; Bassat, Q; Batty, KT; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, BR; Page-Sharp, M; Pomat, W; Robinson, LJ; Salman, S | 1 |
| Deng, C; Guan, X; Guo, J; Jin, C; Li, G; Li, H; Song, J; Tang, Y; Wang, Q; Xie, F; Xu, Q; Yu, W; Yuan, M; Yuan, Y; Zhang, H; Zou, Y | 1 |
| Blessborn, D; Chotsiri, P; Day, NPJ; Hanboonkunupakarn, B; Hoglund, RM; Jittamala, P; Pukrittayakamee, S; Tarning, J; Wattanakul, T; White, NJ | 1 |
| Abong'o, BO; Aljayyoussi, G; Bayoh, NM; Bousema, T; Desai, MR; Gimnig, JE; Kariuki, SK; Kwambai, TK; Ochomo, EO; Phillips-Howard, PA; Samuels, AM; Smit, MR; Ter Kuile, FO; Wang, D; Ward, SA; Waterhouse, D | 1 |
| Abel, H; Bassat, Q; Ila, R; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, B; Pulai, K; Robinson, L; Sanz, S | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Deng, C; Huang, B; Liang, Y; Song, J; Su, Y; Tan, B; Wang, Q; Wu, G; Wu, W; Zhang, H; Zhang, Z; Zhou, C | 1 |
| Darpo, B; Duparc, S; Ferber, G; Laurijssens, B; Macintyre, F; Siegl, P; Toovey, S | 1 |
5 trial(s) available for piperaquine and Long QT Syndrome
| Article | Year |
|---|---|
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Piperazines; Placenta; Pregnancy; Pregnant Women; Quinolines; Uganda | 2022 |
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
Topics: Adult; Antiviral Agents; Artemisinins; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Long QT Syndrome; Lung Diseases; Male; Middle Aged; Quinolines; RNA, Viral; SARS-CoV-2; Viral Load | 2021 |
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Topics: Adult; Antimalarials; Artemisinins; Computer Simulation; Cross-Over Studies; Drug Combinations; Drug Interactions; Electrocardiography; Healthy Volunteers; Heart Rate; Humans; Linear Models; Long QT Syndrome; Middle Aged; Models, Biological; Nonlinear Dynamics; Primaquine; Quinolines; Risk Assessment; Thailand; Young Adult | 2017 |
Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
Topics: Adult; Animals; Anopheles; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Insecticides; Ivermectin; Kenya; Long QT Syndrome; Malaria; Male; Quinolines; Treatment Outcome | 2019 |
Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.
Topics: Adamantane; Adolescent; Adult; Antimalarials; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Peroxides; Quinolines; Young Adult | 2015 |
4 other study(ies) available for piperaquine and Long QT Syndrome
| Article | Year |
|---|---|
Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
Topics: Adult; Antimalarials; Artemisinins; Female; Healthy Volunteers; Humans; Long QT Syndrome; Longitudinal Studies; Malaria, Falciparum; Male; Papua New Guinea; Piperazines; Quinolines | 2022 |
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Healthy Volunteers; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Patient Safety; Prospective Studies; Quinolines | 2018 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients.
Topics: Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Electrocardiography; Female; Humans; Long QT Syndrome; Malaria, Falciparum; Male; Middle Aged; Quinolines; Retrospective Studies | 2019 |